Apogee Therapeutics, Inc. · NASDAQ:APGE

Dambkowski Carl sold 5,500 Apogee Therapeutics, Inc. shares (Form 4)

Traded Aug 5, 2026 · Filed Aug 7, 2026

On Aug 5, 2026, Dambkowski Carl (Chief Medical Officer) sold 5,500 Apogee Therapeutics, Inc. shares at US$134.17 for US$738K under a trading plan, leaving 168,498 shares. Filed Aug 7, 2026 (Form 4).

Sold: 5,500 shares
Price: US$134.17
Value: US$738K
Holding after: 168,498 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Medical Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Aug 5, 2026	Common Stock	Option exercise	4,125	US$22.86	173,998	Direct
Aug 5, 2026	Common Stock	Sale	5,500	US$134.17	168,498	Direct

Source

View original at SEC

Related